NEWS & PERSPCTIVE

Lifestyle intervention reduces mortality risk in men with high-risk prostate cancer

Prostate cancer remains a leading cause of cancer-related deaths in men.1,2 Despite early detection and treatment, the mortality burden of early prostate cancer by 75 years of age remains high.1,2 A recent cohort study has estimated that among men at higher genetic risk, one-third of early prostate cancer deaths were preventable by adherence to a healthy lifestyle, suggesting that prostate cancer prevention strategies should target men with higher genetic risk.1

Prostate cancer is the 4th most common cancer globally, leading to around 400,000 deaths worldwide every year.2 Despite continuous advancement in early detection and treatment for prostate cancer, it continues to be a leading cause of cancer-related deaths in men.1,2 About one-third of prostate cancer-induced deaths occur in those under the age of 75.1 New strategies of prevention are necessary for lowering the burden of early prostate cancer death.1

To investigate the differences between the risk of early prostate cancer death in men with higher vs. lower genetic risk, researchers conducted a cohort study (n=19,607) that analyzed data collected between 1991 and 2019 from two prospective cohorts from the Malmö Diet and Cancer Study (MDCS) and the Health Professionals Follow-up Study (HPFS).1 The MDCS recruited a cohort of 10,270 men with a median age of 59.0, who were free of prostate cancer, had complete lifestyle data available, and were successfully genotyped between 1991 and 1996.1 The HPFS recruited 9,337 male health professionals in the United States, with a median age of 65.1 years, who were free of prostate cancer in 1996 and had available genotype, family history, and lifestyle data from 1986.1 Participants were categorized by their genetic risk and lifestyle score.1

Early prostate cancer death was defined as those occurring by 75 years of age and the rest were classified as late prostate cancer deaths.1 Genetic risk for overall prostate cancer was assessed using a multiancestry polygenic risk score (PRS) that included 400 genetic variants, with participants' PRS calculated from their genotyped data.1 Men at higher genetic risk (n=13,186) were those with a PRS above the median or with a family history of cancer, while the remaining men were at a lower genetic risk (n=6,421).1 A healthy lifestyle was defined by a high score on a previously published lifestyle score for lethal prostate cancer.1,3 One point was assigned for each lifestyle factor (not smoking, healthy weight, high physical activity, high intakes of tomato-based products and fatty fish, and low intake of processed meat).1,3 A score of 3-6 represented a healthy lifestyle while an unhealthy lifestyle was defined by a score of 0-2.1 The healthy group also included men who were nonsmokers with a BMI <30, had high levels of physical activity, and a healthy diet (fulfilling 2 of the dietary components).1

The key primary outcome of this study was the association between genetic risk, lifestyle factors, and death due to prostate cancer.1 Secondary outcomes included age-specific absolute risk (cumulative incidence) of prostate cancer death and the estimated proportion of prostate cancer deaths that would have been prevented by healthy lifestyle adherence.1 Overall, 107 early and 337 late prostate cancer deaths were observed.1 Men at a higher genetic risk had a >3-fold higher risk of early prostate cancer death (HR=3.26; 95% CI: 1.82-5.84), and a >2-fold higher risk of late prostate cancer death.1 88% of early prostate cancer deaths occurred in men with higher genetic risk, of which between 22% (95% CI: 11-34) to 36% (95% CI: 12-60) were estimated to be preventable by healthy lifestyle behaviors.1

In summary, men with a higher genetic risk of prostate cancer had a significantly higher risk of early death by age 75 years, and up to 36% of them were estimated to be preventable.1 Based on this study, targeting men with higher genetic risk with preventative interventions, such as a healthy lifestyle, may significantly reduce early prostate cancer deaths.

Get access to our exclusive articles.
Related Articles